Biomerica, Inc. (BMRA)

NASDAQ: BMRA · IEX Real-Time Price · USD
1.200
-0.020 (-1.64%)
At close: Mar 1, 2024, 4:00 PM
1.260
+0.060 (5.00%)
After-hours: Mar 1, 2024, 7:01 PM EST
-1.64%
Market Cap 20.19M
Revenue (ttm) 5.50M
Net Income (ttm) -6.08M
Shares Out 16.82M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,630
Open 1.220
Previous Close 1.220
Day's Range 1.180 - 1.240
52-Week Range 0.700 - 2.500
Beta -1.09
Analysts n/a
Price Target n/a
Earnings Date Apr 12, 2024

About BMRA

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1971
Employees 62
Stock Exchange NASDAQ
Ticker Symbol BMRA
Full Company Profile

Financial Performance

In 2023, Biomerica's revenue was $5.34 million, a decrease of -71.71% compared to the previous year's $18.87 million. Losses were -$7.14 million, 57.6% more than in 2022.

Financial Statements

News

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Huff was the Former CEO of LabCor...

11 days ago - GlobeNewsWire

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

IRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment ...

5 weeks ago - GlobeNewsWire

Biomerica Reports Second Quarter 2024 Financial Results

IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial res...

6 weeks ago - GlobeNewsWire

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

IRVINE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, today announced it has received U.S. Food a...

2 months ago - GlobeNewsWire

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th An...

4 months ago - GlobeNewsWire

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that several new Gastrointestinal (GI) ...

4 months ago - GlobeNewsWire

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate...

5 months ago - GlobeNewsWire

Biomerica Reports First Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate...

5 months ago - GlobeNewsWire

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide Simple 2 minute at-home test detects an early warning sign of colorectal cancer,...

5 months ago - GlobeNewsWire

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

NEWPORT BEACH, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appoin...

6 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2023 Year End Results

IRVINE, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2023 financial results.

6 months ago - GlobeNewsWire

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that CVS Pharmacy has begun in-store sales rollout of the Company's EZ Detect™ colorect...

7 months ago - GlobeNewsWire

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

IRVINE, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative diagnostic solutions, announced that the China National Intel...

9 months ago - GlobeNewsWire

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, announced a significant adv...

10 months ago - GlobeNewsWire

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, is pleased to announce that inFoods® IBS, ...

11 months ago - GlobeNewsWire

Biomerica Reports Q3 Fiscal 2023 Results

IRVINE, Calif., April 14, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced its fiscal third quarter a...

11 months ago - GlobeNewsWire

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

IRVINE, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced the launch of its InFoods® IBS test. The test is being performed in a CLIA-certified, ...

1 year ago - GlobeNewsWire

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the closing of its previously announced...

1 year ago - GlobeNewsWire

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

IRVINE, Calif., March 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the pricing of its previously announced...

1 year ago - GlobeNewsWire

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today that it has commenced an underwritten p...

1 year ago - GlobeNewsWire

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

IRVINE, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) -- IRVINE, CABiomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its second quarter fiscal 202...

1 year ago - GlobeNewsWire

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company's Scientific Advisory Board

IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) appointed prominent physician and key opinion leader Brian E. Lacy, M.D., Ph.D., a board-certified gast...

1 year ago - GlobeNewsWire

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

Expands Commercialization Efforts in Areas with High Unmet Needs Expands Commercialization Efforts in Areas with High Unmet Needs

1 year ago - GlobeNewsWire

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

IRVINE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) announced that data derived from a clinical study of InFoods® IBS was presented at the 2022 American Co...

1 year ago - GlobeNewsWire

Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores

Shares of Biomerica Inc. BMRA, +7.58% shot up 13.1% toward a 6-month high in active morning trading Friday, after the medical diagnostic products company said Walmart Inc. WMT, +0.45% will start selli...

1 year ago - Market Watch